Published in Infect Immun on June 01, 1993
Identification and characterization of the carbohydrate ligands recognized by pertussis toxin via a glycan microarray and surface plasmon resonance. Biochemistry (2010) 0.98
Aerolysin and pertussis toxin share a common receptor-binding domain. EMBO J (1997) 0.90
Antibody-mediated neutralization of pertussis toxin-induced mitogenicity of human peripheral blood mononuclear cells. Infect Immun (2004) 0.87
Reversal of the CD4(+)/CD8(+) T-cell ratio in lymph node cells upon in vitro mitogenic stimulation by highly purified, water-soluble S3-S4 dimer of pertussis toxin. Infect Immun (2001) 0.86
Mechanistic insight into pertussis toxin and lectin signaling using T cells engineered to express a CD8α/CD3ζ chimeric receptor. Biochemistry (2012) 0.81
Human antibody response to the B oligomer of pertussis toxin. Clin Diagn Lab Immunol (1994) 0.75
Investigation in a murine model of possible mechanisms of enhanced local reactions to post-primary diphtheria-tetanus toxoid boosters in recipients of acellular pertussis-diphtheria-tetanus vaccine. Hum Vaccin Immunother (2014) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
A rapid boiling method for the preparation of bacterial plasmids. Anal Biochem (1981) 59.01
Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc Natl Acad Sci U S A (1979) 44.75
Rapid and efficient cosmid cloning. Nucleic Acids Res (1981) 40.13
Mouse Protection Tests in the Study of Pertussis Vaccine: A Comparative Series Using the Intracerebral Route for Challenge. Am J Public Health Nations Health (1947) 15.54
Plasmids related to the broad host range vector, pRK290, useful for gene cloning and for monitoring gene expression. Plasmid (1985) 11.74
A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol (1970) 8.89
Pertussis toxin gene: nucleotide sequence and genetic organization. Science (1986) 6.02
Specification of surface mating systems among conjugative drug resistance plasmids in Escherichia coli K-12. J Bacteriol (1980) 2.82
Receptor analogs and monoclonal antibodies that inhibit adherence of Bordetella pertussis to human ciliated respiratory epithelial cells. J Exp Med (1988) 2.80
Effect of heptakis (2,6-O-dimethyl) beta-cyclodextrin on the production of pertussis toxin by Bordetella pertussis. Infect Immun (1983) 2.06
Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect Immun (1989) 1.71
Pertussis toxin and target eukaryotic cells: binding, entry, and activation. FASEB J (1992) 1.62
Dual mechanisms involved in development of diverse biological activities of islet-activating protein, pertussis toxin, as revealed by chemical modification of lysine residues in the toxin molecule. Biochim Biophys Acta (1984) 1.62
Effect of monoclonal antibody to pertussis toxin on toxin activity. Infect Immun (1987) 1.61
Pertussis toxin has eukaryotic-like carbohydrate recognition domains. Proc Natl Acad Sci U S A (1992) 1.56
Uptake and intracellular survival of Bordetella pertussis in human macrophages. Infect Immun (1992) 1.56
Adherence of Bordetella pertussis to human respiratory epithelial cells. J Infect Dis (1983) 1.54
Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology. Infect Immun (1987) 1.52
Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough. Infect Immun (1990) 1.44
Adhesion of Bordetella pertussis to sulfatides and to the GalNAc beta 4Gal sequence found in glycosphingolipids. J Biol Chem (1991) 1.41
Modulation of Bordetella pertussis infection with monoclonal antibodies to pertussis toxin. J Infect Dis (1991) 1.32
A one-step procedure for the purification of high molecular weight bacterial chromosomal DNA. Nucleic Acids Res (1988) 1.25
Role of carbohydrate recognition domains of pertussis toxin in adherence of Bordetella pertussis to human macrophages. Infect Immun (1992) 1.24
Adenine nucleotides promote dissociation of pertussis toxin subunits. J Biol Chem (1986) 1.17
Maintenance of biological activity of pertussis toxin radioiodinated while bound to fetuin-agarose. Infect Immun (1987) 1.14
Mapping of linear B-cell epitopes of the S2 subunit of pertussis toxin. Infect Immun (1989) 1.13
Use of glycosyltransferases to restore pertussis toxin receptor activity to asialoagalactofetuin. J Biol Chem (1988) 1.10
Stimulation of the thiol-dependent ADP-ribosyltransferase and NAD glycohydrolase activities of Bordetella pertussis toxin by adenine nucleotides, phospholipids, and detergents. Biochemistry (1986) 1.10
Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine. Infect Immun (1990) 1.08
Monoclonal antibodies that define neutralizing epitopes of pertussis toxin: conformational dependence and epitope mapping. Infect Immun (1989) 1.05
Inhibition of pertussis toxin binding to model receptors by antipeptide antibodies directed at an antigenic domain of the S2 subunit. Infect Immun (1989) 1.04
Gene replacement in Bordetella pertussis by transformation with linear DNA. Biotechnology (N Y) (1990) 0.98
Identification of linear B-cell determinants of pertussis toxin associated with the receptor recognition site of the S3 subunit. Infect Immun (1991) 0.93
Identification of T- and B-cell epitopes of the S2 and S3 subunits of pertussis toxin by use of synthetic peptides. Infect Immun (1992) 0.87
Binding of ATP by pertussis toxin and isolated toxin subunits. Biochemistry (1990) 0.82
Generation of human monoclonal antibodies that confer protection against pertussis toxin. Infect Immun (1992) 0.80
Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med (1974) 6.77
A comparison of low-risk pregnant women booked for delivery in two systems of care: shared-care (consultant) and integrated general practice unit. I. Obstetrical procedures and neonatal outcome. Br J Obstet Gynaecol (1983) 5.78
A comparison of low-risk pregnant women booked for delivery in two systems of care: shared-care (consultant) and integrated general practice unit. II. Labour and delivery management and neonatal outcome. Br J Obstet Gynaecol (1983) 4.22
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J Virol (2002) 4.11
A randomized, controlled trial of vitamin A in children with severe measles. N Engl J Med (1990) 4.07
Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs. Genome Res (2001) 3.97
Air quality and pediatric emergency room visits for asthma in Atlanta, Georgia, USA. Am J Epidemiol (2000) 3.37
Molecular evidence for genus level diversity of bacteria capable of catalyzing anaerobic ammonium oxidation. Syst Appl Microbiol (2000) 3.36
Bioassay of pesticides and industrial chemicals for tumorigenicity in mice: a preliminary note. J Natl Cancer Inst (1969) 3.33
ANTIBACTERIAL PROPERTIES OF PROTAMINE AND HISTONE. Science (1942) 3.32
Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (2000) 3.13
Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1. J Virol (1993) 3.08
Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst (1999) 2.99
A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS. N Engl J Med (1997) 2.84
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation (1994) 2.74
Presynaptic modulation of voltage-dependent Ca2+ current: mechanism for behavioral sensitization in Aplysia californica. Proc Natl Acad Sci U S A (1978) 2.68
A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis. Am J Gastroenterol (2005) 2.63
Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. Proc Natl Acad Sci U S A (1994) 2.62
Obstetrical practice and training in canadian family medicine: conserving an endangered species. Can Fam Physician (1984) 2.45
Mechanism of calcium current modulation underlying presynaptic facilitation and behavioral sensitization in Aplysia. Proc Natl Acad Sci U S A (1980) 2.26
Serotonin modulates a specific potassium current in the sensory neurons that show presynaptic facilitation in Aplysia. Proc Natl Acad Sci U S A (1982) 2.19
N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. Circulation (1994) 2.05
Low birth weight and the battered child syndrome. Am J Dis Child (1971) 2.03
HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques. Nat Med (1995) 1.99
Endosymbiotic sulphate-reducing and sulphide-oxidizing bacteria in an oligochaete worm. Nature (2001) 1.93
[Membrane monoclonal immunoglobulins in chronic lymphoid leukemia]. Rev Eur Etud Clin Biol (1971) 1.91
Bone metastases from differentiated thyroid carcinoma. Endocr Relat Cancer (2008) 1.88
Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol (2010) 1.85
Optical coherence tomography: advanced technology for the endoscopic imaging of Barrett's esophagus. Endoscopy (2000) 1.84
Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk Res (1997) 1.81
Isolations of a cartilage factor that inhibits tumor neovascularization. Science (1976) 1.79
Chédiak-Higashi gene in humans I. Impairment of natural-killer function. J Exp Med (1980) 1.79
A new immunodeficiency disorder in humans involving NK cells. Nature (1980) 1.78
Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function. Cell Immunol (2001) 1.74
Genotype-phenotype correlations of 39 patients with Cornelia De Lange syndrome: the Dutch experience. J Med Genet (2005) 1.72
Rainfall, household crowding, and acute respiratory infections in the tropics. Epidemiol Infect (2011) 1.71
Episiotomy and the second stage of labour. Can Fam Physician (1988) 1.68
The role of race and poverty on steps to kidney transplantation in the Southeastern United States. Am J Transplant (2012) 1.66
Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J Neurochem (2001) 1.64
The significance of grunting in hyaline membrane disease. Pediatrics (1968) 1.62
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Racial disparities in pediatric access to kidney transplantation: does socioeconomic status play a role? Am J Transplant (2012) 1.59
Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion. Diabetologia (2005) 1.58
Temporal and spatial vascularization patterns of unions and nonunions: role of vascular endothelial growth factor and bone morphogenetic proteins. J Bone Joint Surg Am (2012) 1.55
Human HtrA, an evolutionarily conserved serine protease identified as a differentially expressed gene product in osteoarthritic cartilage. J Biol Chem (1998) 1.53
The Arabidopsis thaliana ABC transporter AtMRP5 controls root development and stomata movement. EMBO J (2001) 1.53
Switchable Polymer Based Thin Film Coils as a Power Module for Wireless Neural Interfaces. Sens Actuators A Phys (2007) 1.52
Variations in policies for management of the third stage of labour and the immediate management of postpartum haemorrhage in Europe. BJOG (2007) 1.51
Contracting for trust in family practice obstetrics. Can Fam Physician (1983) 1.50
Epidemiologic features of Strongyloides stercoralis infection in an endemic area of the United States. Am J Trop Med Hyg (1982) 1.49
The repair of experimentally produced defects in rabbit articular cartilage by autologous chondrocyte transplantation. J Orthop Res (1989) 1.48
Nucleotide sequence and in vitro expression of rubella virus 24S subgenomic messenger RNA encoding the structural proteins E1, E2 and C. Nucleic Acids Res (1987) 1.48
Nasopharyngeal oxygen in children. Lancet (1989) 1.48
Advanced Life Support in Obstetrics. Practical approaches to obstetric emergencies. Can Fam Physician (1998) 1.47
Clinical features of Strongyloides stercoralis infection in an endemic area of the United States. Gastroenterology (1981) 1.46
Mental fatigue and task control: planning and preparation. Psychophysiology (2000) 1.46
Should elective lymph node dissection be used for treatment of primary melanoma? J Cancer Res Clin Oncol (1989) 1.44
Removing the need for crossmatched blood in elective EVAR. Eur J Vasc Endovasc Surg (2011) 1.43
Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J Neuropathol Exp Neurol (2000) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Increased exercise after stable closed fracture fixation does not affect fracture healing in mice. J Biomech (2012) 1.41
Chédiak-Higashi gene in humans. II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function. J Exp Med (1980) 1.41
Expression of biological effector functions by immunoglobulin G molecules lacking the hinge region. Proc Natl Acad Sci U S A (1981) 1.41
Integrated wireless neural interface based on the Utah electrode array. Biomed Microdevices (2009) 1.40
Pantoprazole, a proton pump inhibitor, delays fracture healing in mice. Calcif Tissue Int (2012) 1.40
Interim results of the study of particulates and health in Atlanta (SOPHIA). J Expo Anal Environ Epidemiol (2001) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Earthenware containers as a source of fatal lead poisoning. N Engl J Med (1970) 1.38
Synaptic plasticity and the modulation of the Ca2+ current. J Exp Biol (1980) 1.38
Benefits and costs to community-based physicians teaching primary care to medical students. J Gen Intern Med (1998) 1.37
Aetiology and outcome of pneumonia in human immunodeficiency virus-infected children hospitalized in South Africa. Acta Paediatr (2001) 1.37
Hernias are the most common cause of strangulation in patients presenting with small bowel obstruction. Hernia (2006) 1.36
Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. J Clin Invest (1993) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers. J Infect Dis (2001) 1.34
Intracranial haemorrhage associated with hyaline membrane disease. Arch Dis Child (1968) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Care in a birth room versus a conventional setting: a controlled trial. Can Med Assoc J (1984) 1.27
Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study. Osteoporos Int (2007) 1.26
Additional component in the cellular mechanism of presynaptic facilitation contributes to behavioral dishabituation in Aplysia. Proc Natl Acad Sci U S A (1986) 1.25
Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group. Hepatology (1997) 1.25
Small animal bone healing models: standards, tips, and pitfalls results of a consensus meeting. Bone (2011) 1.24
People with absolute pitch process tones without producing a p300. Science (1984) 1.24
Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol (1994) 1.24
Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines. Ann Oncol (2007) 1.24
Second messengers involved in the two processes of presynaptic facilitation that contribute to sensitization and dishabituation in Aplysia sensory neurons. Proc Natl Acad Sci U S A (1990) 1.23
Studies on the Fc gamma receptor of the murine macrophage-like cell line P388D1. I. The binding of homologous and heterologous immunoglobulin G1. J Immunol (1979) 1.23
Limited form of Wegener granulomatosis. Eye involvement as a major sign. JAMA (1975) 1.23
Action-potential duration and the modulation of transmitter release from the sensory neurons of Aplysia in presynaptic facilitation and behavioral sensitization. Proc Natl Acad Sci U S A (1986) 1.23
Cognition is related to resting-state small-world network topology: an magnetoencephalographic study. Neuroscience (2010) 1.22
Factors affecting contrasting results between self-reported and performance-based levels of physical limitation. Age Ageing (1996) 1.22
Increased cancer screening behavior in women of color by culturally sensitive video exposure. Prev Med (1995) 1.21
Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response. J Gen Virol (1996) 1.20
Target-effector interaction in the natural killer cell system. IV. Modulation by cyclic nucleotides. J Immunol (1979) 1.20
Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion. J Virol (1995) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Idiotype-bearing and antigen-binding receptors produced by blood T lymphocytes in a case of human myeloma. Eur J Immunol (1977) 1.19
A plant cold-induced uncoupling protein. Nature (1997) 1.18